March 1, 2022
Frame Therapeutics’ Chief Scientific Officer Wigard Kloosterman will be speaking at different in person scientific conferences the upcoming months. From 26 – 28 April 2022 the 5th Neoantigen Summit Europe takes place in Amsterdam. This summit is dedicated to the robust prediction, identification, and validation of neoantigens to create truly individualized cancer therapeutics. Wigard Kloosterman will be presenting on the identification of Frame neoantigens to develop highly immunogenic cancer vaccines on Wednesday April 27. Find out more and register here.
From 16 – 20 May, The Jackson Laboratory for Genomic Medicine will be organizing a Long-Read Sequencing workshop. Long-read sequencing technologies have emerged as powerful players in genomics over the last few years. Renowned speakers and expert users will share their experiences applying long-read sequencing in basic and translational genomic science and also explore the commonalities and differences in the current technologies. Wigard Kloosterman will talk about Frame’s disease research and clinical applications on Tuesday May 17. The event will be held live at JAX Genomic Medicine in Farmington (Connecticut, USA).
Frame's Principal Scientist Immunology Katka Franke will present results of our work to the broad academic and industrial community at the Cancer Immunotherapy Meeting in Mainz (Germany) on May 12. She will talk about Frame neoantigen discovery and the concept of using these neoantigens in cancer vaccines.